Clinical Trial Update: Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 2/Phase 3 study evaluating different doses of oral melatonin for sleep disorders in patients with chronic kidney di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Sleep Disorders

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Southeast Renal Research Institute | Conditions: End Stage Renal Disease, Chronic Kidney Disease | Phase 2, Phase 3 | Status: UNKNOWN